Unlocking Investment Opportunities: Navigating the BioPharma Landscape in Private Equity and Venture Capital

Join S&P Global Market Intelligence for an insightful webinar tailored for private equity and venture capital professionals, where we will explore the intricate workflow of investing in the BioPharma sector. Led by Bonanza Chalaban, Head of BioPharma Product, Kevin Zacharuk, Head of Private Equity for Data & Research, and moderated by Joe Boo, Visible Alpha Sales Manager, this session will provide a comprehensive overview of the tools and strategies necessary for evaluating investment opportunities in the rare disease market.

Agenda:

• Introduction to the Private Equity and Venture Capital Workflow in BioPharma: Gain insight into the unique considerations and methodologies employed by private equity and venture capital firms in the BioPharma space.
• Understanding Management Views: Use S&P Capital IQ Pro transcripts and filings to assess how company management teams view the opportunity within the rare disease landscape.
• In-Depth Market Research: Leverage S&P Global Aftermarket Research to conduct qualitative analyses through detailed research reports on the rare disease indication.
• Market Size, Competitive Landscape, and Revenue Forecasting: Explore Visible Alpha BioPharma to analyze current market size, revenue by indication, and forward-looking consensus estimates within the competitive landscape for competing drugs, highlighting the potential market opportunities.

This engaging session is designed to equip you with the knowledge and tools needed to make informed investment decisions in the BioPharma sector. Don't miss this opportunity to enhance your understanding of the market dynamics and investment potential within this critical industry.